Trillium Therapeutics' Series C Round

Trillium Therapeutics raised a round of funding on September 18, 2008.

Trillium Therapeutics is a research and development company developing therapies that restore balance to the immune system in conditions associated with aberrant and harmful immune responses, includin…

Articles about Trillium Therapeutics' Series C Round: